Cynosure is a global leader in medical aesthetics, providing innovative energy-based technologies that empower healthcare providers to deliver advanced treatments in dermatology, plastic surgery, and women’s health. With a focus on enhancing patient outcomes, Cynosure offers a comprehensive portfolio of laser and radiofrequency systems designed for hair removal, skin rejuvenation, body contouring, and gynecological treatments.

Committed to excellence and innovation, Cynosure integrates cutting-edge technology with clinical expertise to create versatile, effective, and safe solutions. Its systems are engineered to deliver precise, predictable, and high-quality results, helping clinicians meet the growing demand for aesthetic and medical treatments worldwide. By combining scientific research, rigorous testing, and user-focused design, Cynosure ensures that both patients and providers experience superior performance and satisfaction.

In January 2024, Cynosure merged with Lutronic, another leader in laser and RF technologies, forming a powerful global entity in the medical aesthetics industry. This merger strengthened the company’s product portfolio, expanded its global reach, and reinforced its mission to provide innovative solutions that improve patient care and treatment outcomes.

Driven by a dedication to quality, innovation, and clinical excellence, Cynosure continues to shape the future of medical aesthetics, helping practitioners worldwide deliver safe, effective, and transformative treatments while setting new standards for the industry.